Drug Interactions and Side Effects of Lunesta and Tracleer and Synthroid and Altace and Effexor and Zolpidem Tartrate and Amlodipine Besylate and Warfarin Sodium and Verapamil and Spironolactone and Propoxyphene Hydrochloride and Mycophenolate Mofetil and Atenolol and Pilocarpine and Fluticasone Propionate
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 117019 | May, 9, 2006 | 68 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Lunesta | eszopiclone |
Tracleer | bosentan |
Synthroid | levothyroxine sodium |
Altace | ramipril |
Effexor | venlafaxine hydrochloride |
Zolpidem Tartrate | zolpidem tartrate |
Amlodipine Besylate | amlodipine besylate |
Warfarin Sodium | warfarin sodium |
Verapamil | verapamil hydrochloride |
Spironolactone | spironolactone |
Propoxyphene Hydrochloride | propoxyphene hydrochloride |
Mycophenolate Mofetil | mycophenolate mofetil |
Atenolol | atenolol |
Pilocarpine | pilocarpine hydrochloride |
Fluticasone Propionate | fluticasone propionate |
| Name |
Alanine Aminotransferase Increased |
Aspartate Aminotransferase Increased |
Blood Alkaline Phosphatase Increased |
Drug Interaction |
Results from eHealthMe : 2 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Alanine Aminotransferase Increased | 2 (100.00%) |
Aspartate Aminotransferase Increased | 2 (100.00%) |
Blood Alkaline Phosphatase Increased | 2 (100.00%) |
Drug Interaction | 2 (100.00%) |
Top 3 (total: 13. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Claritin | 1 (2.78%) |
Flonase | 1 (2.78%) |
Amitriptyline Hcl | 1 (2.78%) |
Death reported: 0
| Name | Count (% of total reports) |
Drug Interaction | 2 (100.00%) |
Alanine Aminotransferase Increased | 2 (100.00%) |
Blood Alkaline Phosphatase Increased | 2 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports: